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ABSTRACT 
 
Aims: To generate new medicaments for control and treatment of the parasitic protozoan 
Toxoplasma gondii. 
Study Design: Structure similarity search and isostere search was conducted over a broad range 
of structure categories. Correlation and highest similarity scores were implemented to select the 
best drug candidates. 
Place and Duration of Study: University of Nebraska, Department of Chemistry, Durham Science 
Center, 6001 Dodge Street, Omaha Nebraska 68182, from June 2016 to February 2017. 
Methodology: Utilizing pyrimethamine as the parent compound, a broad range of similar structures 
and isosteres were found by applying search methods. The compounds having the highest 
correlation and similarity scores were selected for the study of molecular properties. The molecular 
properties were determined and examined for underlying relationships by pattern recognition 
hierarchical cluster analysis and K-means cluster analysis.  
Results: Thirty compounds were identified to have a very high level of structure similarity or 
isosteric relationship to pyrimethamine. The molecular structures and molecular properties are 
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presented for all compounds, inclusive of pyrimethamine. Hierarchical cluster analysis and K-means 
cluster analysis indicated compounds with highest underlying similarity to pyrimethamine. Box plots 
showed the over-all distribution of important pharmaceutical properties, such as molecular weight, 
Log P, polar surface area, number of rotatable bonds, molecular volume, and number of hydrogen 
bond donors. Structure components are compared to elucidate potential clinical activity. Multiple 
regression is applied on all compounds to generate a numerical relationship for prediction of similar 
compounds. Save for only one isostere, all compounds showed zero violations of the Rule of 5, 
indicating favorable drug-likeness and bioavailability. 
Conclusion: Thirty compounds highly analogous to pyrimethamine were identified following 
heuristic search course. The molecular properties were determined for all compounds and indicated 
genuine potential for treatment of toxoplasmosis. Correlation of structure and pattern recognition 
methods indicated 30 compounds of clinical potential and property analogy to pyrimethamine.  
 
 
Keywords: Protozoan; Toxoplasma gondii; pyrimethamine; antimalarial; isosteres.  
 
ABBREVIATIONS 
  
PSA: Polar surface area; MW: Molecular weight; nOHNH: Number of hydroxyl and amine groups; 
nON: Number of oxygen and nitrogen atoms.  
 
1. INTRODUCTION  
 
Toxoplasma gondii (T. gondii) causes 
toxoplasmosis, and is an intracellular, obligate, 
parasitic protozoan [1]. T. gondii is found 
worldwide and is one of the most common 
parasites in developed countries, with up to 
23.6% in places in Africa [1,2,3]. Healthy adults 
may not show any symptoms of infection, 
however, individuals having weakened immune 
systems the infection can cause serious to fatal 
consequences [2]. Epidemiology studies have 
shown that up to 84% of individuals in France are 
infected [4].  
 
Infection with T. gondii has been shown to be 
associated with various neurological disorders, 
and in particular schizophrenia [5]. Infection with 
T. gondii can occur by eating poorly cooked or 
raw meat that contains the T.  gondii tissue cysts 
[6]. For North America, the greatest threat for 
infection comes from raw or poorly cooked pork 
[6]. Other modes of infection include blood 
transfusions, organ transplant, unpasteurized 
goat milk, soil contact, and consumption of 
contaminated vegetables/fruits [6]. The Protozoa 
group are diverse unicellular eukaryotic 
organizms, most of which range in size from 10 
micrometers to 52 micrometers [7]. These 
organisms are abundant in aqueous 
environments and soil [7]. Other protozoan 
diseases associated with humans include                  
[7]: Malaria, Amoebiasis, Giardiases, 
Trichomoniasis, Chagas disease, Leishmaniasis, 
Sleeping Sickness, and Amoebic dysentery. 
Antiprotozoal agents (ATC code: ATC PO1) are 
grouped together as medicinal applied in the 
clinical treatment of protozoan infection [8]. This 
group of medicinal agents are distinguish by their 
mechanism of action or by organism type, they 
include the following [8,9,10]: eflornithine, 
furazolidone, metronidazole, ornidazole, 
pentamidine, pyrimethamine, and tinidazole. 
Pyrimethamine (5-(4-chlorophenyl)-6-ethyl-2,4-
pyrimidinediamine) is well absorbed, 
administered orally, has a high protein binding 
capacity, and is excreted by the kidneys [11].  
There is widespread resistance to 
pyrimethamine, and the side effects include 
nausea, vomiting, headache, and diarrhea [7]. 
Despite this, pyrimethamine is considered among 
the most important medications for basic health 
maintenance. This due to a large part to the 
serious socio-economic and health burden of 
Toxoplasma gondii proliferation in developed and 
developing nations [12].  
 
Structure-based drug design is most efficacious 
when it is a part of a complete drug lead 
discovery process (i.e. new designs for additional 
clinical medicaments). Substitution of 
substituents of a parent compound (simplest 
member of a group of compounds) pursues the 
objective of chemical similarity that includes the 
generation of isosteres. The entity having 
chemical similarity (or molecular similarity), refers 
to the similarity of chemical elements with 
respect to either structural and/or the biological 
effect of the chemical compound [13]. 
 
  
 
 
Bartzatt; BJPR, 16(4): 1-12, 2017; Article no.BJPR.33205 
 
 
 
3 
 
Computer-aided drug discovery/design methods 
have played a major role in the development of 
therapeutically important small molecules [13].  
Computer-aided drug design has enabled the 
focus of drug discovery to achieving the best 
potency against a biological target of interest, 
and favorable absorption, distribution, 
metabolism, and excretion (ADME) [13]. A 
heuristic approach employs a practical method 
(not necessarily optimal), but sufficient for the 
immediate goals. When finding an optimal 
solution is impractical, heuristic methods can be 
used to speed up the process of finding a 
satisfactory solution [13]. 
 
Clearly, the study and development of additional 
drug agents to combat Toxoplasma type 
infections is of great importance. This study 
presents novel derivatives of pyrimethamine by 
heuristic structure search and isostere 
identification. The drug pyrimethamine 
possesses substituents on the aromatic ring that 
facilitates and makes efficacious the isosteric 
substituent of atoms. The compounds that result 
are shown to have efficacious molecular 
properties when compared to the parent drug 
pyrimethamine and by their similarity score. 
 
2. METHODOLOGY  
 
2.1 Properties and Molecular Modeling 
 
For all 31 compounds included in this study, the 
numerical values of molecular properties were 
determined by utilizing heuristic techniques of 
Molinspiration (Molinspiration Cheminformatics, 
Nova ulica 61, SK-900 26 Slovensky Grob, 
Slovak Republic). Similarity search and isostere 
elucidation was accomplished by Molinspiration. 
Similarity scoring and correlation to 
pyrimethamine for all structures was 
accomplished by Molinspiration. Construction 
and presentation of molecular structure was 
accomplished by use of ACD ChemSketch 
Modeling v. 12.01 (Advanced Chemistry 
Development, 110 Yonge Street, Toronto 
Ontario, M5C 1T4 Canada) and Molinspiration 
(http://www.molinspiration.com/services/search.h
tml) 
 
2.2 Pattern Recognition and Multivariate 
Statistical Analysis 
 
Identification of underlying associations and 
patterns within the numerical values of molecular 
properties done by use hierarchical cluster 
analysis and K-means cluster analysis. 
Hierarchical cluster analysis was performed by 
KyPlot v. 2.0 (copyright Koichi Yosioka 1997 to 
2001 and K-means cluster analysis was 
performed by PAST v. 2.06 (copyright Oyvind 
Hammer, D.A.T. Harper 1999-2008). 
 
2.3 Various Statistical Analysis Data 
 
Methods of statistical analysis applied included 
Pearson r correlation and univariate descriptive 
statistics were accomplished by Microsoft 
EXCEL v. 14.0.6112.5000 (EXCEL Professional 
plus 2010). Pearson r correlation was also 
determined by using PAST v. 2.06. Multiple 
regression by Graph Pad Instat version 3.00 
(GraphPad Software, Inc., San Diego, California 
USA; www.graphpad.com). Box plots were 
generated by PAST v. 2.06. Grubb’s test for 
outliers accomplished by Graph Pad Quick Calcs 
(http://www.graphpad.com/ quickcalcs/index.cfm) 
 
3. RESULTS AND DISCUSSION 
 
3.1 Structure and Properties  
 
Therefore, the computer-aided heuristic similarity 
search accompanied by isostere identification 
has revealed 30 new molecular structures for the 
treatment of protozoan T. gondii infections. The 
chemical structure of pyrimethamine with the six 
isostere compounds is presented for comparison 
in Fig. 1. The pyrimethamine molecule and six 
isosteres have various attributes in common. All 
seven compounds have an aromatic ring and a 
pyrimidine ring having a primary amine group (or 
pyrimidin-2-amine group), with a second primary 
amine group and one ethyl substituent (or 6-
ethylpyrimidine-2, 4-diamine group).  
 
The pyrimethamine structure has a 4-
chlorophenyl group covalently attached to the 6-
ethylpyrimidine-2,4-diamine framework. The 
isosteres are formed upon substitution of the 4-
chloro atom with analogous atoms (i.e. same 
number of atoms and/or the same number of 
valence electrons). The selection of the isostere 
substitutions were selected to optimize drug 
likeness of the new formed compounds and 
maintain the attributes of isostere (i.e. maintain 
same number of atoms/valence electrons).  
Isosteres are known to be effective for enhancing 
drug likeness [13,14,15,16]. 
 
This accomplished, compound (2) has a 
phosphane group (-PH2) substituting for the 
chlorine atom of pyrimethamine drug (see Fig. 1).  
Following in order, compounds 3, 4, 5, 6,          
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and 7 have the following atoms substituting              
for the chlorine atom of pyrimethamine, 
respectively: 
 
(3) –SH atoms; (4) –F atom; (5) –OH atoms; 
(6) –NH2 atoms; and (7) –CH3. The 
alterations these substitutions bring about on 
the molecular properties are presented in 
Table 1 and will be discussed next.  
 
For most drugs, the preferred route of 
administration is by oral ingestion [13].  
Therefore, investigators seek the 
physicochemical properties that favor intestinal 
absorption [13,14]. The rule-of-5 (RO5) is a rapid 
screen for compounds likely to fit the parameters 
of drug-likeness and have favorable membrane 
permeation and bioavailability [14]. The RO5 was 
formulated after examination of over 2000 known 
drugs and observing that orally administered 
drugs are relatively small and moderately 
lipophilic molecules [14]. The RO5 states that if a 
compound violates any two of the following  
rules, it is likely to exhibit poor intestinal 
absorption [14]: 1) Molecular weight greater than 
500; 2) Number of hydrogen bond donors more 
than 5 (where, a donor being any O-H or                  
N-H group); 3) Number of hydrogen bond 
acceptors more than 10 (where, an acceptor 
being any O or N including those in donor 
groups); and 5) Calculated Log P greater than 
5.0.   
 
CCc1nc(N)nc(N)c1c2ccc(Cl)cc2
CH3
NH2
NH2 Cl
N
N
PH2
CH3
NH2
NH2
N
N
SH
CH3
NH2
NH2
N
N
F
CH3
NH2
NH2
N
N
OH
CH3
NH2
NH2
N
N
NH2
CH3
NH2
NH2
N
N
CH3
CH3
NH2
NH2
N
N
CCc1nc(N)nc(N)c1c2ccc(P)cc2
CCc1nc(N)nc(N)c1c2ccc(S)cc2
CCc1nc(N)nc(N)c1c2ccc(F)cc2
CCc1nc(N)nc(N)c1c2ccc(O)cc2
CCc1nc(N)nc(N)c1c2ccc(N)cc2
CCc1nc(N)nc(N)c1c2ccc(C)cc2
1
2
3
4
5
6
7
Pyrimethamine
 
 
Fig. 1. Isosteres (molecules or ions with the same number of atoms and/or the same number of 
valence electrons) of pyrimethemine (1) 
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Table 1. Molecular properties of compounds 
 
Drug Log P Polar surface 
area 
(Angstroms2) 
Number 
of 
atoms 
Molecular 
weight 
Number of oxygen 
& nitrogen atoms 
Number of 
-OH &  
-NHn 
Violations 
of rule of 5 
Number 
of rotatable 
bonds 
Volume 
(Angstroms3) 
1 Pyrimethamine 2.84 77.83 17 248.72 4 4 0 2 216.62 
2  isostere 2.82 77.83 17 246.25 4 4 0 2 222.49 
3  isostere 2.39 77.83 17 246.34 4 4 0 2 220.74 
4  isostere 2.32 77.83 17 232.26 4 4 0 2 208.01 
5  isostere 1.68 98.06 17 230.27 5 5 0 2 211.10 
6  isostere 1.23 103.85 17 226.29 5 6 1 2 214.37 
7  isostere 2.61 77.83 17 228.30 4 4 0 2 216.64 
8 2.16 77.83 16 214.27 4 4 0 2 203.09 
9 2.85 45.75 17 228.29 3 1 0 3 221.99 
10 4.05 17.31 17 242.71 2 0 0 1 210.75 
11 3.33 30.20 17 264.12 3 0 0 1 203.57 
12 1.48 84.93 17 230.27 5 3 0 2 211.91 
13 1.81 54.87 17 250.69 4 1 0 2 210.67 
14 3.00 34.38 17 222.25 3 0 0 2 199.64 
15 2.51 34.90 18 307.19 3 0 0 3 240.26 
16 2.38 34.90 18 262.74 3 0 0 3 235.91 
17 1.15 55.12 18 244.29 4 1 0 3 230.39 
18 4.05 17.31 17 242.71 2 0 0 1 210.75 
19 4.08 34.38 19 270.72 3 0 0 2 229.74 
20 2.02 46.09 18 241.29 4 0 0 4 228.83 
21 4.28 17.31 17 263.13 2 0 0 1 207.73 
22 1.71 45.75 15 200.24 3 1 0 1 188.39 
23 1.34 93.62 16 213.24 5 5 0 0 187.84 
24 3.77 17.31 17 246.68 2 0 0 1 199.12 
25 3.65 17.31 16 228.68 2 0 0 1 194.19 
26 3.40 34.38 18 236.27 3 0 0 2 216.20 
27 3.45 83.64 18 264.67 6 1 0 3 212.97 
28 3.51 17.83 17 242.71 2 0 0 1 210.75 
29 1.42 55.12 19 258.32 4 1 0 4 247.19 
30 2.55 39.43 18 239.28 4 0 0 2 218.60 
31 4.18 17.31 17 287.16 2 0 0 1 215.10 
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Shown in Table 1, for compounds 1 to 7 in       
Fig. 1, all seven compounds show favorable 
bioavailability and membrane penetration 
(favorable drug-likeness) with zero violations of 
RO5, with agent 6 showing only one violation of 
the RO5. This is a beneficial and favorable 
outcome for the efficacy of these six isosteres of 
pyrimethamine. In addition, previous studies 
have shown that drugs having polar surface area 
(PSA) greater than 140 Angstroms2 are poorly 
absorbed [13,15]. Note, that all agents 1 to 7 
have PSA less than 103.85 Angstroms2 and are 
expected to be well-absorbed following ingestion.  
Other properties of pyrimethamine have a very 
strong negative relationship (Pearson’s r 
correlation less than -0.7000) for PSA, number of 
–OH, -NHn, oxygen atoms, and nitrogen atoms. 
The molecular weight (MW) of pyrimethamine is 
a very strong positive correlation to MW of all six 
isosteres (Pearson r = 0.7031).  
 
The compounds presented in Fig. 2 are derived 
from heuristic search for chemical similarity to 
pyrimethamine. Compounds 8 through 19 
showed a similarity score to pyrimethamine of 
0.66 to 0.87. The greater the similarity score, the 
higher the correlation to pyrimethamine.  
Compounds 8 through 19 have a very broad 
variation in molecular scaffolding, however, the 
molecular properties are still showing zero 
violations of RO5, indicating favorable drug-
likeness to bioavailability. 
 
Compounds 8 to 19 show aromatic rings, hetero-
atomic aromatic rings, halogen atoms, and 
aliphatic substituents. Overall the variation in 
structure is broad, however consistency in 
molecular properties with the features of 
pyrimethamine is clear and paramount.  
 
The compounds presented in Fig. 3 are derived 
from heuristic search for chemical similarity to 
pyrimethamine. Compounds 20 through 30 
showed a similarity score to pyrimethamine of 
0.62 to 0.65. The greater the similarity score, the 
higher the correlation to pyrimethamine.  
Compounds 20 through 31 have a very broad 
variation in molecular scaffolding, however, the 
molecular properties are still showing zero 
violations of RO5, indicating favorable drug-
likeness to bioavailability.  
 
Compounds 20 to 31 show aromatic rings, 
hetero-atomic aromatic rings, halogen atoms, 
and aliphatic substituents. Overall the variation in 
structure is broad, however consistency in 
molecular properties with the features of 
pyrimethamine is clear and paramount.  
Looking at the whole of Table 1, the molecular 
properties, the Grubb’s test for outliers showed 
no outliers for all 31 agents in the following 
descriptors: Log P, polar surface area, number of 
atoms, molecular weight, number of oxygen & 
nitrogen atoms, number of –OH and –NHn 
groups, number of rotatable bonds, and 
molecular volume. This result is a clear indication 
that the six isosteres and remaining 24 
compounds are extremely consistent in 
properties. This and the favorable indicator for 
favorable bioavailability supports the contention 
that these 30 novel drug designs would have 
efficacy of biological activity analogous to 
pyrimethamine and potential clinical application. 
 
3.2 Pattern Recognition Identification of 
Interrelationships 
 
Structural similarity is one of the basic underlying 
principles in drug discovery and development 
[16]. The basic underlying principle of compound 
subset selection and structure-activity 
relationship studies presumes that compounds 
which are similar to biologically active molecules 
should themselves also be active, and vice versa 
[16]. Therefore, determination of similarity is 
among the most intensively studied areas with 
numerous methods published [16].  
 
In data mining, hierarchical cluster analysis is a 
method of cluster analysis that seeks to build a 
hierarchy of clusters [17,18]. Cluster Analysis 
goals are to relate the grouping a collection of 
objects (i.e., observations, individuals, cases, or 
data rows) into subsets or clusters, where  those 
within each cluster are more closely related to 
one another than objects assigned to different 
clusters [17,18]. Central to cluster analysis is the 
concept of degree of similarity (or dissimilarity) 
between the individual objects being clustered. 
There are two major methods of clustering: 
hierarchical clustering and K-means clustering. 
Both will be applied to this study. 
 
The Dendrogram presented in Fig. 4 shows the 
results of hierarchical cluster analysis of all 31 
agents presented in Table 1. Conditions of 
cluster analysis are Euclidean distance and 
single-linkage clustering (distance between one 
cluster and another cluster is equal to the 
shortest distance from any member of one 
cluster to any member of the other cluster) [17, 
18]. The Dendrogram is divisive approach with all 
observations starting in one cluster (A), and then 
splitting as it moves down the hierarchy. 
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CH3
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N
N
Clc1ccc(cc1)c2cn3ccc(C)cc3n2
8
9
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Cl
Cl
N
N
N
Clc1ccc(cc1Cl)c2cn3cccnc3n2
NH2
OH
CH3
CH3
N
N
N
Nc1nc(nc(n1)C(C)(C)O)c2ccccc2
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CH3 O
O
N
N
H
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14
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16
17
18
19
O
N
N
O=Cc1c(nc2ccccn12)c3ccccc3
OH
O
CH3
CH3 N
N
BrCCN1C(C)=C(C(=O)N=C1C)c2ccccc2
Br
O
CH3
CH3 N
N
ClCCN1C(C)=C(C(=O)N=C1C)c2ccccc2
Cl
O
CH3
CH3 N
N
OCCN1C(C)=C(C(=O)N=C1C)c2ccccc2
Cc1ccc(cc1)c2cn3cc(Cl)ccc3n2
Cl
CH3
N
N
O
CH3
Cl
N
N
Clc1ccc(cc1)c2nc3ccc(C)cn3c2C=O
 
 
Fig. 2. Outcome of heuristic similarity search with compounds having similarity score  
0.66 to 0.87 
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20
21
22
23
24
25
OCH3
CH3
N
N
N
O=C(Cc1cc(ncn1)N(C)C)c2ccccc2
Cl
N
N
Cl
Clc1ccc(cc1)c2cn3cc(Cl)ccc3n2
CH3
CH3
O
N
N
H
O=C2NC(C)=NC(C)=C2c1ccccc1
NH2
NH2
CH3
N
N
NH
Cc3cc2c(ccc1nc(N)nc(N)c12)n3
Fc1ccc(cc1)c2cn3cc(Cl)ccc3n2
Cl
F
N
N
Clc1ccc(cc1)c2cn3ccccc3n2
26
27
28
29
30
31
Cl
N
N
O
CH3
N
N
Cc1ccc2nc(c(C=O)n2c1)c3ccccc3
CH3
Cl
NH
NN
N
O O
Cc2nc(Cl)nc(Nc1ccccc1)c2N(=O)=O
Cl
CH3
N
N
Clc1cc2nc(C)n(c2cc1)c3ccccc3
OH
OCH3
CH3
N
N
CC1=C(C(=O)N=C(C)N1CCCO)c2ccccc2
CH3CH3
O
N
N
N
COc1ccc(cc1)c2cn3ccc(C)nc3n2
Br
CH3
N
N
Brc1ccc(cc1)c2cn3ccc(C)cc3n2
 
 
Fig. 3. Outcome of heuristic similarity search for compounds having similarity scores  
0.62 to 0.65 
 
In divisive cluster analysis, all objects 
(compounds) begin in cluster A, but then are 
resolved into clusters holding analogous agents 
steadily until all 31 agents are distinguished. 
Leading from node A, agent 6 (isostere) is 
determined to be unique from the remaining 30 
agents, most likely due to the highest polar 
surface area (103.85 Angstroms2). Agent 6, 27, 
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22, and 23 are determined to be distinguished 
from all other agents found under node B. Agent 
19 is determined to be distinct from all other 
agents found under node B, potentially due to a 
very high Log P (4.08), but with a low polar 
surface area (34.38 Angstroms2). Virtually all the 
remaining agents are found under node C, 
leading to node D containing agents 8, 12, 5, 7, 
4, 3, 2, and 1 (pyrimethamine). Ultimately, the 
agents most similar to pyrimethamine (agent 1) 
are the isosteres 2, 3, 4, and 7. This outcome is 
accordant that isostere compounds are    
molecules or ions having the same number of 
atoms and/or the same number of valence 
electrons. 
 
K-means cluster analysis an 
unsupervised algorithm to solve the clustering 
goal. The method classifies a data set to a 
certain number of clusters determined prior to 
analysis [18]. Again, the outcome are a number 
of clusters chosen before analysis where each 
drug is designated with other drugs that have the 
highest similarity [18]. The result of K-means 
cluster analysis of agents shown in Table 1 are 
following, with isosteres represented in bold:  
 
Cluster 1: 11, 19, 21, and 31. 
Cluster 2: 13, 16, 17, 20, and 29. 
Cluster 3: 1 (pyrimethamine), 2, 3, 4, 5, 6, 7, 8, 
12, 23, and 27. 
Cluster 4: 9, 10, 14, 18, 22, 24, 25, 26, 28, and 
30. 
Cluster 5: 15. 
 
Interestingly, all isosteres found in search engine 
are determined to have the highest similarity to 
the parent compound pyrimethamine (cluster 3).  
This result is consistent with hierarchical cluster 
analysis. In addition, agents 8, 12, 23, and 27 are 
added to cluster 3. Compound 15 (cluster 5) is 
determined to be distinct from all other 
compounds. The determination of isosteres of 
pyrimethamine shows to be of the highest 
similarity among 30 compounds selected                        
by search engine is consistent for both 
approaches to cluster analysis (hierarchical and 
K-means). 
 
Box plots or box and whisker diagrams is a 
standardized statistical method to visualize the 
displaying the distribution of data based on the 
five number summary: minimum, first quartile, 
median, third quartile, and maximum [18]. Box 
and whisker plots are very useful when large 
numbers of observations are involved and when 
two or more data sets are being compared.  
Boxplots display two common measures of the
 
 
 
Fig. 4. Hierarchical cluster analysis of compound molecular properties presented in Table 1. 
Analysis utilized standard Euclidean distance with single linkage for clusters. Super-node A, 
encompassing all compounds, is divided into clusters of compound (see Table 1) based on 
highest similarity.  Node B excludes compounds 22, 27, and 6. Node C excludes 15, 16, 17, 20, 
29, 19, 23, 22, 27, and 6. Node D includes compounds 1, 2, 3, 4, 7, 5, 12, and 8.  Node E includes 
compounds 1, 2, 3, 4, and 7 
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variability or spread in a data set: Range the 
spread of all the data; and Interquartile range 
(the middle half of a data set falls within the 
interquartile range). 
 
Observing the box plots for molecular properties 
(see Fig. 5), the medians are indicated within the 
box with the range by the whiskers [18]. The box 
plots show visually the relative position of the 
medians and ranges of each molecular property 
listed in Table 1. The broadest ranges (maximum 
to minimum) are found with polar surface area, 
molecular weight, and volume. Their ranges, 
respectively, are 17.31 Angsroms2 to 103.85 
Angstroms2, 200.24 Dalton to 307.19 Dalton,         
and 187.84 Angstroms3 to 247.19        
Angstroms3. 
 
Interestingly, most molecular properties have a 
very small range from minimum to maximum that 
are very close to the median. These descriptors 
are Log P, number of atoms, number of oxygen 
& nitrogen atoms, number of –OH & -NHn 
groups, violations of the rule of 5, and number of 
rotatable bonds. The oxygen, nitrogen, hydroxyl 
(-OH), and amine (-NHn) groups account for the 
hydrogen bond acceptor and hydrogen bond 
donor characteristic of the molecule. These 
values, shown in the box plots, are highly 
consistent for all 31 agents and very small in 
range (i.e. having whiskers very close to the 
medians).  
 
Utilizing box plots presented in Fig. 5, it is readily 
seen that numerical values from minimum to 
maximum is small and are extremely close to the 
median, upper, and lower quartile (except for 
PSA, molecular weight, and molecular volume).  
Most of the descriptors of all 30 compounds are 
highly consistent, numerically close in proximity, 
and very close to the group medians.  In addition, 
and further evidence the 31 compounds have 
very strong positive relationship are results of 
Pearson correlation of one compound to another 
(applying all properties, see Table 1), are all 
greater than 0.9700. Taken together, the box 
plots and Pearson r correlation clearly show that 
pyrimethamine, isosteres, and similarity search 
structures are very highly similar and with 
properties indicating clinically favorable drug-
likeness, permeability, and membrane 
penetration.
  
 
 
Fig. 5. Box plots of properties presented in Table 1, with whiskers of one standard deviation 
This representation shows numerical dispersion of values and range of numerical values 
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3.3 Multiple Regression and Prediction  
 
Multiple regression analysis is a powerful 
technique for predicting the value of an 
dependent variable from the known value of two 
or more independent variables, referred to as 
predictors [19]. In this analysis, the predictors are 
molecular properties such as Log P and polar 
surface area, having significance as 
pharmaceutical properties. For compounds 1 to 
31, and utilizing the properties given in Table 1, 
we can form analysis with Log P, polar surface 
area (PSA), number of atoms (nAtoms), number 
of oxygen & nitrogen atoms (nON), number of –
OH and –NHn, molecular volume (MV), and 
number of rotatable bonds (nRotB):  
 
MW = -85.632 + 11.026(LogP) – 
0.1324(PSA) – 9.156(nAtoms) + 
14.362(nON) – 5.014(nOHNH) + 5.445 (rule 
of 5) – 15.523(nRotB) + 2.107(MV)            (1) 
 
The relationship (1) shows an R2 of 0.7060, 
indicating the model accounts for 70.60% of the 
variance in MW based on the model. The 
dependent variables of greatest significance are 
the Log P (P=.02), number of rotatable bonds 
(P=.04), and molecular volume (P=.01).   
 
Various techniques disseminated to find better 
medicines faster include QSAR (Quantitative 
structure–activity relationship), structure based 
techniques, homology modelling (generating a 
homologous structure to the parent drug), and 
high throughput screening [20]. This study has 
demonstrated the efficacy of applying isosteres 
and similarity search utilizing heuristic search 
engine. Isosteres for lead modification has been 
shown to be highly successful approach to 
modify the activity of a lead drug (pyrimethamine 
here) and modify toxicity [21]. Applying isosteres 
in drug design has been highly successful, in part 
due to the only subtle changes of size, shape, 
Log P, and hydrogen bonding [21]. The use of in-
silico chemistry and molecular modeling has 
great momentum and potential [22]. In-silico 
methods will continue to have substantial 
importance in prediction of novel drugs [22].  
 
This study has shown that specific isostere 
substitution and rational similarity search 
produced 30 potential agents for anti-protozoan 
usage. The drug pyrimethemine has been shown 
to be effective for treatment of protozoa 
diseases. The 30 agents presented here have 
favorable drug-likeness based on the rule of 5 
(i.e. good bioavailability and membrane 
permeation [14]). Their properties are modified 
only slightly and be statistical analysis are shown 
to adhere to rigid analogy to parent drug 
pyrimethemine. With the great success of 
isostere modification of a successful lead, these 
30 agents (2 to 31) have potential to be useful in 
the clinical treatment of protozoan diseases.  
 
4. CONCLUSION 
 
Pyrimethamine is an important drug for the 
treatment of protozoan infections. Thirty agents 
were identified to be analogous to pyrimethamine 
following heuristic search engine, six of the 
agents as isosteres. The result of search engine 
identified 30 agents that were highly consistent in 
important pharmacological properties such as 
Log P and polar surface area. Grubb’s test for 
outliers showed no outlying values for Log P, 
polar surface area, molecular weight, and four 
other molecular properties. All compounds in this 
study showed favorable bioavailability, having 
zero violations of the rule of 5. Hierarchical 
cluster analysis and K-means cluster analysis 
showed that the isostere compounds were most 
similar to pyrimethamine. Multiple regression 
analysis produced a mathematical model for 
predicting properties of compounds of similar 
medicinal use. The study and design of new 
medicinal agents for treatment of protozoan 
infections is a vital endeavor with great demand 
in the future. 
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